Basilea Pharmaceutica AG (SWX:BSLN)

Basilea Pharmaceutica AG Balance Sheet

Financials in millions CHF. Fiscal year is January - December.

Assets

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Short-Term Investments	-	-	-	-	95
Cash & Short-Term Investments	-	-	-	-	95
Cash Growth	-	-	-	-	-5.96%
Accounts Receivable	13.49	8.88	27.89	33.15	24.95
Other Receivables	49.79	49.31	30.26	28.55	39.5
Total Trade Receivables	63.28	58.18	58.15	61.7	64.45
Inventory	21.56	31.61	26.41	24.24	22.78
Other Current Assets	7.1	10.41	7.65	4.76	5.14
Total Current Assets	251.73	220.91	152.15	175.36	241.07
Net Property, Plant & Equipment	18.15	18.98	20.55	21.57	2.92
Other Intangible Assets	0.37	0.37	0.55	0.58	0.63
Other Long-Term Assets	11.75	17.5	0.04	23.34	2.65
Total Assets	282	257.76	173.29	220.85	247.27

Liabilities

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	15.06	11.49	5.85	0.19	10.62
Accrued Expenses	30.52	30.39	23	33.97	38.16
Current Portion of Long-Term Debt	-	-	15.45	37.47	123.51
Current Portion of Leases	2.06	2.06	2.06	1.99	0.9
Unearned Revenue	1.57	1.62	1.23	1.23	1.23
Total Current Liabilities	49.22	45.56	47.59	74.85	174.41
Long-Term Debt	75.44	95.91	95.46	131.36	94.54
Long-Term Leases	11.72	13.7	15.64	16.32	0.01
Other Long-Term Liabilities	17.69	21.6	24.61	19.03	36.91
Total Long-Term Liabilities	104.84	131.21	135.7	166.71	131.47
Total Liabilities	154.06	176.77	183.29	241.56	305.87

Shareholders' Equity

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	13.32	13.17	13.1	13.09	12.99
Treasury Stock	-51.28	-51.7	-54.01	-56.07	-56.56
Additional Paid-in Capital	1,052	1,048	1,042	1,037	1,030
Accumulated Other Comprehensive Income	-3.9	-4.74	-10.21	-3.78	-21.62
Retained Earnings	-882.57	-923.29	-1,001	-1,011	-1,023
Shareholders' Equity	127.94	81	-10	-20.72	-58.61
Total Liabilities & Equity	282	257.76	173.29	220.85	247.27

Additional Metrics

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	89.22	111.67	128.61	187.14	218.96
Net Cash (Debt)	-89.22	-111.67	-128.61	-187.14	-123.96
Net Cash Growth	-	-	-	-	-
Net Cash Per Share	-6.52	-8.06	-10.59	-15.67	-10.61
Book Value	127.94	81	-10	-20.72	-58.61
Book Value Per Share	9.35	5.85	-0.82	-1.73	-5.02
Tangible Book Value	127.57	80.63	-10.55	-21.29	-59.24
Tangible Book Value Per Share	9.32	5.82	-0.87	-1.78	-5.07

Data Source: Fiscal.ai Last updated: Nov 14, 2025

Financial data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Aug 2, 2026

Data Sources Report a data error